Cargando…
A meta-analysis of clinicopathologic features that predict necrosis or fibrosis at post-chemotherapy retroperitoneal lymph node dissection in individuals receiving treatment for non-seminoma germ cell tumours
PURPOSE: Post-chemotherapy retroperitoneal lymph node dissection (pcRPLND) for residual nodal masses is a critical component of care in metastatic testicular germ cell tumour (GCT). However, the procedure is not of therapeutic value in up to 50% of individuals in whom histopathology demonstrates pos...
Autores principales: | Conduit, Ciara, Hong, Wei, Martin, Felicity, Thomas, Benjamin, Lawrentschuk, Nathan, Goad, Jeremy, Grimison, Peter, Ahmadi, Nariman, Tran, Ben, Lewin, Jeremy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428700/ https://www.ncbi.nlm.nih.gov/pubmed/36059636 http://dx.doi.org/10.3389/fonc.2022.931509 |
Ejemplares similares
-
Two decades of FDG-PET/CT in seminoma: exploring its role in diagnosis, surveillance and follow-up
por: Conduit, Ciara, et al.
Publicado: (2022) -
Retroperitoneal Lymph Node Dissection as Primary Treatment for Metastatic Seminoma
por: Hu, Brian, et al.
Publicado: (2018) -
The role of primary retroperitoneal lymph node dissection in the treatment of stage II seminoma
por: Sigg, Silvan, et al.
Publicado: (2023) -
Retroperitoneal lymph node dissection for germ cell tumour
por: Tran, Vy, et al.
Publicado: (2020) -
Retroperitoneal Lymph Node Dissection Should Be a Standard-of-Care Treatment Option For Stage II Seminoma
por: Alsyouf, Muhannad, et al.
Publicado: (2023)